Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Zakir Gaffoor

Datos Biográficos

ID7727304
NOMBREZakir Gaffoor
NOMBRESZakir
APELLIDOGaffoor
FIRMAGAFFOOR Z
AFILIACIONESSouth African Medical Research Council
VERIFICADONo
TOTAL DE OBRAS10
TOTAL DE CITAS0
TOTAL COMO AUTOR10
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2016
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H0
  • Sars-CoV-2 seroprevalence among learners in grades 1–7, their parents and teachers in KwaZulu-Natal, South Africa

    Open Access•Reshmi Dassaye, Terusha Chetty et al.•ARTICLE•Frontiers in Public Health•2025

    Introduction: There is limited information on SARS-CoV-2 seroprevalence among children and adolescents in LMIC school settings. We aimed to assess (1) the seroprevalence of SARS-CoV-2 antibodies, (2) prevalence of self-reported or confirmed SARS-CoV-2 prior infections and, (3) COVID-19 symptoms (including long-COVID) among a cohort of primary school learners, their parents and teachers in a semi-rural school setting approximately 3-years into the…

  • Efficacy of the Dapivirine Vaginal Ring Accounting for Imperfect Adherence

    Open Access•Marla Husnik, Renee Heffron et al.•ARTICLE•AIDS and Behavior•2024

  • Intimate Partner Violence and Engagement in the HIV Care Continuum among Women in Sub-Saharan Africa

    Open Access•Sarah T Roberts, Ariane Van Der Straten et al.•ARTICLE•AIDS and Behavior•2022

  • Integrating Gender-Based Violence Screening and Support into the Research Clinic Setting

    Open Access•Morgan Garcia, Sarah T Roberts et al.•ARTICLE•AIDS and Behavior•2022

    HIV and gender-based violence (GBV) are syndemic in sub-Saharan Africa and provision of support for participants who disclose GBV constitutes part of comprehensive care. Consequently, a process was undertaken to develop, implement, and evaluate standard operating procedures (SOPs) in MTN-025/HOPE, a study of the dapivirine vaginal ring for HIV prevention. The SOP was developed using needs assessment surveys in addition to World Health Organizatio…

  • Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020/Aspire study

    Open Access•Morgan Garcia, Ellen Luecke et al.•ARTICLE•BMC Public Health•2021

    Our analysis supports the growing body of work illustrating the importance of meaningfully engaging research participants to achieve study success and aligns with other analyses of adherence support efforts during ASPIRE. While causation between PEA attendance and product use cannot be established, residual drug levels in returned rings strongly correlated with participant attendance at PEAs, and the benefits of incorporating PEAs should be consi…

  • Correlates of Adherence to the Dapivirine Vaginal Ring for HIV-1 Prevention

    Open Access•Marla Husnik, Elizabeth R Brown et al.•ARTICLE•AIDS and Behavior•2021

  • Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial

    Open Access•Ashley Mayo, Erica N Browne et al.•ARTICLE•AIDS and Behavior•2021

    We evaluated the acceptability of the 25 mg dapivirine vaginal ring (DVR) as an HIV prevention intervention and its influence on DVR adherence in the MTN-020/ASPIRE phase III trial. Acceptability measures were captured using ACASI at month 3 and end of product use (median 24 months, IQR 15-30). Monthly returned rings were classified as nonadherent if dapivirine release rate was ≤ 0.9 mg/month. Associations between acceptability measures and nonad…

  • The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence

    Open Access•Marie C D Stoner, Elizabeth R Brown et al.•ARTICLE•AIDS and Behavior•2021

  • Impact of Male Partner Involvement on Women’s Adherence to the Dapivirine Vaginal Ring During a Phase III HIV Prevention Trial

    Open Access•for the MTN-020/ASPIRE Team, Sarah T Roberts et al.•ARTICLE•AIDS and Behavior•2019

  • Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

    Jared M Baeten, Thesla Palanee‐phillip et al.•ARTICLE•New England Journal of Medicine•2016

    BACKGROUND: Antiretroviral medications that are used as prophylaxis can prevent acquisition of human immunodeficiency virus type 1 (HIV-1) infection. However, in clinical trials among African women, the incidence of HIV-1 infection was not reduced, probably because of low adherence. Longer-acting methods of drug delivery, such as vaginal rings, may simplify use of antiretroviral medications and provide HIV-1 protection. METHODS: We conducted a ph…

Sin obras prominentes en esta página.

  • Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

    Jared M Baeten, Thesla Palanee‐phillip et al.•ARTICLE•New England Journal of Medicine•2016

    BACKGROUND: Antiretroviral medications that are used as prophylaxis can prevent acquisition of human immunodeficiency virus type 1 (HIV-1) infection. However, in clinical trials among African women, the incidence of HIV-1 infection was not reduced, probably because of low adherence. Longer-acting methods of drug delivery, such as vaginal rings, may simplify use of antiretroviral medications and provide HIV-1 protection. METHODS: We conducted a ph…

  • Impact of Male Partner Involvement on Women’s Adherence to the Dapivirine Vaginal Ring During a Phase III HIV Prevention Trial

    Open Access•for the MTN-020/ASPIRE Team, Sarah T Roberts et al.•ARTICLE•AIDS and Behavior•2019

  • Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020/Aspire study

    Open Access•Morgan Garcia, Ellen Luecke et al.•ARTICLE•BMC Public Health•2021

    Our analysis supports the growing body of work illustrating the importance of meaningfully engaging research participants to achieve study success and aligns with other analyses of adherence support efforts during ASPIRE. While causation between PEA attendance and product use cannot be established, residual drug levels in returned rings strongly correlated with participant attendance at PEAs, and the benefits of incorporating PEAs should be consi…

  • Correlates of Adherence to the Dapivirine Vaginal Ring for HIV-1 Prevention

    Open Access•Marla Husnik, Elizabeth R Brown et al.•ARTICLE•AIDS and Behavior•2021

  • Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial

    Open Access•Ashley Mayo, Erica N Browne et al.•ARTICLE•AIDS and Behavior•2021

    We evaluated the acceptability of the 25 mg dapivirine vaginal ring (DVR) as an HIV prevention intervention and its influence on DVR adherence in the MTN-020/ASPIRE phase III trial. Acceptability measures were captured using ACASI at month 3 and end of product use (median 24 months, IQR 15-30). Monthly returned rings were classified as nonadherent if dapivirine release rate was ≤ 0.9 mg/month. Associations between acceptability measures and nonad…

  • The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence

    Open Access•Marie C D Stoner, Elizabeth R Brown et al.•ARTICLE•AIDS and Behavior•2021

  • Intimate Partner Violence and Engagement in the HIV Care Continuum among Women in Sub-Saharan Africa

    Open Access•Sarah T Roberts, Ariane Van Der Straten et al.•ARTICLE•AIDS and Behavior•2022

  • Integrating Gender-Based Violence Screening and Support into the Research Clinic Setting

    Open Access•Morgan Garcia, Sarah T Roberts et al.•ARTICLE•AIDS and Behavior•2022

    HIV and gender-based violence (GBV) are syndemic in sub-Saharan Africa and provision of support for participants who disclose GBV constitutes part of comprehensive care. Consequently, a process was undertaken to develop, implement, and evaluate standard operating procedures (SOPs) in MTN-025/HOPE, a study of the dapivirine vaginal ring for HIV prevention. The SOP was developed using needs assessment surveys in addition to World Health Organizatio…

  • Efficacy of the Dapivirine Vaginal Ring Accounting for Imperfect Adherence

    Open Access•Marla Husnik, Renee Heffron et al.•ARTICLE•AIDS and Behavior•2024

  • Sars-CoV-2 seroprevalence among learners in grades 1–7, their parents and teachers in KwaZulu-Natal, South Africa

    Open Access•Reshmi Dassaye, Terusha Chetty et al.•ARTICLE•Frontiers in Public Health•2025

    Introduction: There is limited information on SARS-CoV-2 seroprevalence among children and adolescents in LMIC school settings. We aimed to assess (1) the seroprevalence of SARS-CoV-2 antibodies, (2) prevalence of self-reported or confirmed SARS-CoV-2 prior infections and, (3) COVID-19 symptoms (including long-COVID) among a cohort of primary school learners, their parents and teachers in a semi-rural school setting approximately 3-years into the…

Medicine (10 obras) · HIV/AIDS Research and Interventions (9 obras) · Environmental health (7 obras) · Family medicine (6 obras) · Family planning (6 obras) · HIV, Drug Use, Sexual Risk (6 obras) · Nursing (6 obras) · Public health (6 obras) · Vaginal ring (6 obras) · Health psychology (5 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae